Table 1.
Demographics and baseline characteristics (safety analysis set/full analysis set; N = 153)
| Variable | Value |
|---|---|
| Sex, n (%) | |
| Men | 108 (70.6) |
| Women | 45 (29.4) |
| Age(years), mean(s.d) | 56.1 (10.4) |
| Duration of diabetes(years), mean(s.d.) | 9.07 (5.55) |
| Body weight (kg), mean(s.d.) | 72.12 (14.87) |
| BMI (kg/m2), mean(s.d.) | 26.52 (4.47) |
| Diabetic complications, n (%) | |
| Total | 68 (44.4) |
| Diabetic retinopathy | 24 (15.7) |
| Diabetic neuropathy | 16 (10.5) |
| Diabetic nephropathy | 51 (33.3) |
| Non‐diabetic complications, n (%) | |
| Hypertension | 89 (58.2) |
| Hyperlipidaemia | 128 (83.7) |
| HbA1c (%), mean(s.d.) | 8.14 (0.94) |
| Fasting plasma glucose(mg/dL), mean(s.d.) | 177.3 (34.8) |
| eGFR(mL/min/1.73m2), mean(s.d.) | 86.7 (19.2) |
aFasting plasma glucose: 1 mg/dL = 0.0555 mmol/L.